跳至主要内容
临床试验/CTIS2023-508316-27-00
CTIS2023-508316-27-00进行中(未招募)1 期

Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. A phase IV clinical trial. - LIVERGREE

Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron0 个研究点目标入组 173 人开始时间: 2023年11月28日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
173

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients with liver tumors with an indication for minimally invasive surgery, evaluated by the hospital’s multidisciplinary liver tumor board (MDTB)., Contrast enhanced MRI within 6 weeks prior to liver surgery, =18 years old, Absence of exclusion criteria and able to provide consent for data collection and analysis

排除标准

  • Emergency surgery, Patients in which ICG is contraindicated (one condition will be enough for excluding the patient): 1.previous history of iodine hypersensitivity; 2. patients with renal failure (GFR <60 mL/min/1.73 m2); 3 uremic syndrome; 4. clinical hyperthyroidism; 5. autonomic thyroid adenomas; or 6. focal and diffuse autonomic abnormalities of the thyroid gland., Previous liver surgery

研究者

发起方
Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron

相似试验

Preoperative Indocyanine Green administration... | 临床试验